Recommendations for the use of Herpes Zoster vaccines

Dooling, Kathleen L.

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Recommendations for the use of Herpes Zoster vaccines

May 10, 2018
By Dooling, Kathleen L.

[PDF-2.14 MB]

English

Details Supporting Files You May Also Like

Details:

Personal Author:

Dooling, Kathleen L.
Corporate Authors:

Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations. ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Division of Emergency Operations. ; National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Less -
Description:

Date: Thursday, May 10, 2018

Time: 2:00pm-3:00pm (Eastern Time)

Herpes zoster, also known as shingles, is a common viral disease with about one million cases each year in the United States. In October 2017, the Food and Drug Administration (FDA) approved a 2-dose, recombinant zoster vaccine ([RZV], Shingrix), for the prevention of herpes zoster in adults aged ≥50 years. The Centers for Disease Control and Prevention (CDC) recommends Shingrix for use in immunocompetent adults age ≥50 years. During this COCA Call, clinicians will learn about CDC recommendations for herpes zoster vaccines and the clinical guidelines for the new vaccine.

slides_051018_herpes_zoster_vaccines.pdf
Content Notes:

ACIP Recommendations for the use of herpes zoster vaccines / Kathleen Dooling.
Document Type:

Presentation
Place as Subject:

Herpes Zoster/prevention & control ; Herpes Zoster Vaccine

Herpes Zoster/prevention & control ; Herpes Zoster Vaccine Less -
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:a3ec1f53830c4c3c651e253301858784c00f2213100c930b6e328a5dc1ffcd53
Download URL:

https://stacks.cdc.gov/view/cdc/55589/cdc_55589_DS1.pdf
File Type:

video_051018_herpes_zoster_vaccines.mp4

mp4

More +